Abstract
Abstract
Background
Poorly coordinated care can have major impacts on patients and families affected by rare conditions, with negative physical health, psychosocial and financial consequences. This study aimed to understand how care is coordinated for rare diseases in the United Kingdom.
Methods
We undertook a national survey in the UK involving 760 adults affected by rare diseases, 446 parents/carers of people affected by rare diseases, and 251 healthcare professionals who care for people affected by rare diseases.
Results
Findings suggested that a wide range of patients, parents and carers do not have coordinated care. For example, few participants reported having a care coordinator (12% patients, 14% parents/carers), attending a specialist centre (32% patients, 33% parents/carers) or having a care plan (10% patients, 44% parents/carers). A very small number of patients (2%) and parents/carers (5%) had access to all three—a care coordinator, specialist centre and care plan. Fifty four percent of patients and 33% of parents/carers reported access to none of these. On the other hand, a higher proportion of healthcare professionals reported that families with rare conditions had access to care coordinators (35%), specialist centres (60%) and care plans (40%).
Conclusions
Care for families with rare conditions is generally not well coordinated in the UK, with findings indicating limited access to care coordinators, specialist centres and care plans. Better understanding of these issues can inform how care coordination might be improved and embrace the needs and preferences of patients and families affected by rare conditions.
Funder
Health Services and Delivery Research Programme
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference33 articles.
1. Rare Disease UK. What is a Rare Disease? www.raredisease.org.uk/what-is-a-rare-disease/. Accessed 17 Jan 2021.
2. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–73. https://doi.org/10.1038/s41431-019-0508-0.
3. European Commission. EU Research on Rare Diseases. https://ec.europa.eu/info/researchand-innovation/research-area/health-research-and-innovation/rare-diseases_en. Accessed 17 Jan 2021.
4. Walton H, Hudson ME, Simpson A, Ramsay AI, Kai J, Morris S, Sutcliffe AG, Fulop NJ. Defining coordinated care for people with rare conditions: a scoping review. Int J Integr Care. 2020;20(2):14.
5. Rare Disease UK. The rare reality—an insight into the patient and family experience of rare disease. 2016. www.raredisease.org.uk/media/2361/patient-experiences-2015.pdf. Accessed 22 Oct 2021.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献